Delaware SUPPORT Office Based Opioid Treatment (OBOT) Fellowship - Practice Implementation Track: June 16, 2021
Elements of Competence
This CE activity has been designed to improve learner competence and performance and focuses on the American Board of Medical Specialties’ areas of patient care and procedural skills and medical knowledge.
This activity focuses on the Interprofessional competencies of roles/responsibilities, interprofessional communication, and teams/teamwork.
This activity also focuses on the Institute of Medicine competencies of provide patient-centered care, work in interdisciplinary teams and employ evidence-based practice.
This program is intended for administrators on identification of opioid use disorder and the process involved with OBOT.
At the conclusion of the activity, the administrative healthcare team members will be able to:
- Describe at least three different OBOT workflows
- Identify which workflows fit best or may be adapted to their practice setting
- Describe at least two different scheduling templates
- Identify which scheduling templates fit best or may be adapted to their practice setting
Clinical Director/Planning Committee Chair(s):
Krishna Winfrey, BS, Principal Researcher
Maliha Ali, MBBS, DrPH, Researcher
Quy Nhi Cap, MPH, Researcher
Daniel Harwell, MS, Researcher
Sarah Mossburg, BSN, MS, PhD, Researcher
Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, FACPM, DFASAM
Mishka Terplan, MD MPH FACOG DFASAM
Claire Viscione, BS, Research Assistant
Additional Committee Members:
Anika Alvanzo, MD, Physician
Amanda Brooks, LCSW CADC, Licensed Clinical Social Worker and Certified Alcohol and Drug Counselor
Kathryn Basques, MSW MSN, APN, PMHMP-BC, Nurse Practitioner
Megan Buresh, MD, Physician
Nicole Michele Gastala, MD, Physician
Terry Horton, MD, FACP, DABAM, Physician
POLICY ON DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).
For this educational activity, all conflicts of interest have been resolved and detailed disclosures are listed below:
Financial Relationship Disclosures
Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation?
|Maliha Ali, MBBS, DrPH||Committee Member||No relevant financial relationships to disclose||No|
|Anika Alvanzo, MD||Speaker/Author||American Society of Addiction Medicine (Fiduciary Officer), Maryland Department of Health and Mental Hygiene (Contractor); Pyramid Healthcare, Inc. (Employment)||No|
|Terese Bailey, BS||Planner||No relevant financial relationships to disclose||No|
|Kathryn Basques, MSW, MSN, APN, PMHMP-BC||Speaker/Author||No relevant financial relationships to disclose||Yes|
|Amanda Brooks, LCSW, CADC||Speaker/Author||No relevant financial relationships to disclose||No|
|Megan Buresh, MD||Speaker/Author||American Society of Addiction Medicine (Contractor)||No|
|Quy Nhi Cap, MPH||Committee Member & Planner||No relevant financial relationships to disclose||No|
|Nicole Gastala, MD||Speaker/Author||No relevant financial relationships to disclose||No|
|Daniel Harwell, MS||Committee Member||No relevant financial relationships to disclose||No|
|Terry Horton, MD, FACP, DABAM||Speaker/Author||Masimo (Consultant and Advisory Group Member)||No|
|Sarah Mossburg, BSN, MS, PhD||Committee Member||No relevant financial relationships to disclose||No|
|Elizabeth Salsbury-Afshar, MD, MPH, FAAFP, FACPM, DFASAM||Committee Member, Speaker/Author, Content Reviewer||No relevant financial relationships to disclose||No|
|Mishka Terplan, MD, MPH, FACOG, DFASAM||Committee Member, Speaker/Author, Content Reviewer||No relevant financial relationships to disclose||No|
|Claire Viscione, BS||Committee Member||No relevant financial relationships to disclose||No|
|Krishna Winfrey, BS||Committee Member||No relevant financial relationships to disclose||No|
*The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and American Institutes on Research (AIR). The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
|The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 ANCC contact hours.|
Continuing Education Units (CEUs)
|The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 CEUs or 1.0 hour.|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™